Quarterly report pursuant to sections 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
 3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Operating Activities:    
Consolidated net loss $ (8,817) $ (6,602)
Adjustments to reconcile consolidated net loss to net cash provided by (used in) operating activities:    
Fair value adjustments 35,844 (94)
Depreciation and amortization of intangibles 3,173 2,974
Deferred income taxes 3,270 0
Amortization of debt discount 1,557 225
Non-cash compensation 367 630
Amortization of deferred financing fees 112 108
Inventory valuation 97 0
Loss (gain) on derivatives (70) 5
Bad debt expense (34) 208
Interest expense added to Plant Owners' debt 0 2,276
Gain on extinguishment of debt 0 (817)
Changes in operating assets and liabilities:    
Accounts receivable (16,096) (6,326)
Inventories (5,008) (1,300)
Prepaid expenses and other assets 82 53
Prepaid inventory 2,974 (4,222)
Accounts payable and accrued expenses 5,425 6,428
Net cash provided by (used in) operating activities 22,876 (6,454)
Investing Activities:    
Additions to property and equipment (1,833) (309)
Purchases of New PE Holdco ownership interests 0 (1,639)
Net cash used in investing activities (1,833) (1,948)
Financing Activities:    
Proceeds from exercise of warrants 12,130 2,064
Net proceeds from Kinergy's line of credit 4,065 847
Principal Payments on Plant Owners' borrowings (19,378) (3,500)
Principal Payments on senior notes (13,007) (1,880)
Principal payments on capital leases (1,096) 0
Principal payments on related party note (750) 0
Proceeds from senior notes 0 22,192
Proceeds from Series A Convertible Notes 0 6,000
Proceeds from Plant Owners' borrowings 0 4,000
Parent purchases of Plant Owners' debt 0 (23,357)
Debt issuance costs 0 (1,044)
Preferred stock dividends paid (312) (312)
Net cash provided by (used in) financing activities (18,348) 5,010
Net increase (decrease) in cash and cash equivalents 2,695 (3,392)
Cash and cash equivalents at beginning of period 5,151 7,586
Cash and cash equivalents at end of period 7,846 4,194
Supplemental Information:    
Interest paid 2,712 737
Noncash financing and investing activities:    
Reclass of warrant liability to equity upon warrant exercises 11,377 260
Reclass of noncontrolling interest to APIC upon acquisition 0 8,161
Discount on senior and convertible debt 0 4,940
Preferred stock dividends paid in common stock $ 0 $ 732